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cardiaccardioversionis highlyeffectiveand safe. However,the
characteristicsof patientswho benefitmost fromthis invasive
techniqueareunknown.
Methods.Weprospectivelystudied25consecutivepatientswith
chronicatrial fibrillation(11 & 9 months).All patientshad
undergoneat leastthreeattemptsat conventionalexternaltrans-
thoraciccardioversionbymeansof paddlesin an anteropo8tero-
Iateralpositionapplyingenergiesup to 360 J withoutsucce8s.
Intracardiacshocksweredeliveredby an externaldefibrillator
throughdefibrillationelectrodesplacedin the rightatriumand
coronarysinusor in the rightatriumandleftpulmonaryartery.
Afterconversion,all patientswere treatedorallywith sotalol
(mean194&63 mglday).
ResuUs.Internalcardioversionwas successfulin 22 of 25
patientsat a meandefibrillationthresholdof 6.5 &3.0 J. Mean
leadimpedancewas56.4 &7,4Q. No severecomplicationswere
observed.Ata meanfollow-upof 15 k 12months,12(55%)ofthe
patientstreatedsuccessfullyremainedin sinusrhythm.
Corzdu.sioras.In patientswith failed externalcardioversion,




Atrial fibrillationis a commonarrhythmia;its incidenceis







applicationof externalhigh energyshocks.Successrates of
40% to 70%havebeen describedwith antiarrhythmicdrugs
(6-11). The reportedsuccessrate for externalcardioversion
rangesfrom 61% to 90% (12–14).Advancedcathetertech-
niquesaimedat restoringsinusrhythmhavebeen evaluated
(15-17)inpatientswithfailedexternalcardioversionandatrial
fibrillationnot well tolerated despite medication.Internal
cardioversionof atrial fibrillationby these techniquesused
highenergies,rangingfrom 100to 360J, and appliedeither
totallyright-sidedintracardiacor right atrial catheter-chest
wallelectrodesystems.
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atrial fibrillationhave proved effectivein animals(18–21).
After promisingresultsin a pilot study(1) that showedthat
internalcardioversionis feasible,we focusedon a ditlerent





atrial fibrillationat least 2 weeksin duration(mean [MD]
11~ 9months,range1to 36)inwhomexternalcardioversion,






withwarfarinfor at least 2 weeks(internationalnormalized
ratio IINR]2.7to 4.2).Patientswereexcludedfromthe study
if there wasanyevidenceof digitalistoxicity,abnormalelec-
trolytelevelsor hyperthyroidism.Furthermore,patientswith
an acutemyocardialinfarctionwithinthe past 6 weekswere
excluded,aswellas patientswitha previoushisto~ of embo-
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The benefitsand risksof the studywerediscussedwithall
patients.An informedconsentform was obtainedfrom all
patientsbasedontheprotocolandapprovalofthestudybythe
EthicsCommitteeof the Klinikumrechtsder IsaronApril27,
1993.













burns, and a limitof three shocks.If the final360-Jshock
failed,internalcardioversionwas attemptedin a subsequent
session,
Protocolfor internal conversion.A temporary,custom-
built6F catheter(Elecath)with an activesurfaceof 2,5cm2
consistingofnineparallelstainless teelringswasinsertedinto
the rightfemoralveinandpositionedin the lowerrightatrium
sothat themajorityof thecatheterelectrodeshadfirmcontact
with the right atrial free wall. This catheter served as the
defibrillationcathode.Pacingand recordingof atrial signals
wasperformedbythe distalelectroderingsof thiscatheter.A
seconddefibrillationelectrodewasplacedin eitherthe coro-
nary sinus (Fig. 1) or the left pulmonaryartery. In eight
patients,therightinternaljugularveinwascannulatedto place
the defibrillationelectrodein the coronarysinus.The left
pulmonaryartery catheterwas advancedby either the right
antecubitalvein or the right femoralvein. Central venous
punctureswere performed at INR levelsup to 2.0 (after
warfarinwaswithheldfor 1 to 2 days).Internalcardioversion
wasperformedin the cardiaccatheterizationlaboratory.Seda-
tionwasachievedwith5 mgof diazepamorally.Immediately
beforecardioversion,2.0to 8 mg of midazolamwasadminis-
tered intravenously.
Table 1. ClinicalCharacteristics of 25 StudyPatients
Pt Age(yr)l Height Weight BMI LADiameter AFDuration
No. Gender (cm) (kg) (kg/m’) (mm) (me)
1 53/F 160 75 29.3 60 19
2 48iM 172 93 31.4 60 26
3 56jM 192 95 25.8 63 16
4 53/M 170 69 23.9 59 6
5 51M 176 93 30.0 68 5
6 41/M 195 103 27.1 58 4
7 56/M 181 94 28.2 60 1
8 60iM 185 85 24.8 60 11
9 60iM 179 85 26.5 74 12
10 47jM 182 64 19.3 46 16
11 69/F 172 95 32.1 65 10
12 46IM 185 95 27.8 56 9
13 66/M 185 115 36.3 63 36
14 76iF 163 62 23.3 76 7
15 48I’M 172 93 31.4 60 26
16 58/F 165 70 25.7 62 6
17 69/M 179 72 22.5 73 4
18 68iIvf 174 76 25.1 80 4
19 56IM 168 77 27.3 59 9
20 58iM 176 80 25.8 60 7
21 471M 185 95 27.8 56 1
22 46IM 176 80 25.8 59 11
23 58iM 180 95 28.2 65 11
24 52iM 183 88 26.3 42 7
25 59iM 180 94 28.1 62 1
Mean 56 177 86 27 62 11
&SD t9 t8 t13 ?3 *8 ?9
AF = atrialfibrillation;BMI= bodymassindex;F = female;LA= leftatrial;M = male;Pt = patient.
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Figure1. Posteroanterolateral projection in a patient
with previous aortocoronary bypass surgery.The right
atrialdefibrillationcatheterisappliedthrougha femoral
veinapproach.In thispatient,a quadripolarcatheterfor
recordingof intraatrialsignalsand stimulationof the
atrium is also placed in a low right atrial location
throughthe femoralaccess.The seconddefibrillation
catheteris placedin the coronarysinus.
Defibrillation threshold was definedas the lowestshock
intensitythat convertedatrial fibrillationto sinus rhythm.
Biphasicshocksof3 and2 mswithphasesseparatedby0.2ms
wereused.The shocksweredeliveredby an externaldefibril-
lator (VentritexHVS-02)and synchronizedto the R wave.
Beforeapplicationoftheshocks,a custom-builtECGamplifier
and filterwith variablegain was adjustedto ensurecorrect
synchronization,whichwas confirmedvisuallyon an oscillo-
scope(Gould6000S, Gould,Ilford,UnitedKingdom).Start-
ingwitha testshockof60V, theenergywasincreasedin 40-V
steps until cardioversionwas achieved.Criteriafor quitting
were patient discomfort,complicationsuch as inductionof
proarrhythmiaand shockenergies>15 J. At least 1 minwas
permitted to elapse between unsuccessfuldefibrillationat-
tempts,beforethe nextshockwasapplied.Duringthe study,
the 12-leadECG and intraatrialsignalswere recordedand






tientdepartment.A 12-leadECGwasobtainedat the 1-,3-,6-,
9- and 12-monthfollow-upvisitsor earlier if the patient
experiencedsymptomssuggestiveof recurrentatrial fibrilla-
tion.Aftereffectivecardioversionto sinusrhythm,allpatients
were treated with sotalolat least 80 mg twicea day (mean
194t 63 mgjday,range 160to 400).Angiotensin-converting
enzyme-inhibitors,diureticdrugsand digitaliswere also ad-
ministeredaccordingto the clinicalstatusof the patient.In
patients with persistentsinus rhythm, anticoagulationwas
stopped4 weeksafter successfulrestorationof sinusrhythm.
Statisticalanalysis. Continuousvariablesare expressedas
meanvalue* SD.Statisticalanalysiswasperformedusingthe
Mann-WhitneyU test for unpairedgroups.Recurrencedata
were analyzedusing life-tablesurvivalanalysis.A p value
<0.05 was considered statistically significant.
Results
Clinical characteristics and general results. The study
included25patients(Table1) (meanage56 * 9 years,range
41 to 76; 21 men, 4 women)with a mean bodymass index
(BMI)of 27 f 3 kg/m2(range 19 to 37), mean durationof
atrialfibrillationof 11* 9 months(range1to 36)anda mean
echocardiographiclongitudinaleft atrial diameterof 62 f
8mm(range42to 80).Externalcardioversionhadfailedin all
25 patientsat energiesup to 360 J (5 J/kg). Unsuccessful
pharmacologiconversionhad beenattemptedin 18of the 25
patientsbeforeexternalcardioversion(Table2).
Internalcardioversionwassuccessfulin 22of25patientsat
a mean defibrillationthresholdof 6.5 ~ 3.0J and mean lead
impedanceof 56.4* 7.4Q Withcatheterspositionedin the
Figure 2. Surface ECG leads I, II, III, VI and V5are showntogether
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Table2. Failureof PharmacologicandExternalCardioversionAttemptsand Successof
InternalCardioversion
External Internal
Pt Pharmacologic CVEnergy CVDFT Locationof InternalCV Relapse Follow-Up











































































































































































































CV= cardioversion;CS= coronarysinus;DFT= defibrillationthreshold;NS= nosuccess;PA= leftpulmonary
artery;PS= partialsueeess,sinusrhythm<1 minaftercardioversion;Pt = patient;S = sueeess.
rightatriumand coronarysinus,the mean energyfor cardio-
v&sionwas4.7Y3.0J; forthe rightatriumandleftpulmonary
artery configuration,the defibrillationthresholdwas signifi-




versionwasunsuccessfulin all 25 patients;however,internal
cardioversionrestoredsinusrhythmin22of25patients.In two
of the three patientsfor whominternalcardioversionfailed,





betweenenergyrequirementsand left atria]size (p < 0.05).
There was no significantcorrelationof energyrequirements
and durationof atrialfibrillationand BMI(p > 0.05)in this
study.
Long-termclinicaloutcome.Onan intentionto treatbasis,
12 (55%) of 22 patients successfullytreated with internal
cardioversionwere in sinusrhythmafter a meanfollow-upof
15 ~ 12 months (range 0.2 to 33). In 10 patients, atria]
fibrillationrecurredafter a meanof 1.332.0 months.Figure
4 depictsthe life-tableanalysisshowingthe cumulativepro-
portionof patientsremainingin sinusrhythmafter successful
internalcardioversion.
Figore3. Correlationof energyrequirementsandleft atrialdiameter
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lation into sinus rhythmare treatmentwith antiarrhythmic
drugs and external high energy cardioversionduring full
sedation.Previousreportsshowedsuccessratesof40%to 7070
(6-11) for antiarrhythmicdrugsand 61%to 90%(12-14)for
externalcardioversion.We found a successrate of 88Y0for
conversionof chronicatrialfibrillationbyinternallowenergy
cardioversionin patients in whom attemptedexternalhigh
energycardioversionhad failed.
The exactmechanismsfor the highersuccessrate at lower
energieswithinternalcardioversioncan onlybe inferred.The
creation of a homogeneouselectricalfield with sufficient
strengthismandatoryfor conversionofventricularfibrillation
(22). The same may hold true for atrial fibrillation.With
respectto homogeneityof fieldstrength,one wouldassume
thatthedirectapplicationoftheenergyto therightatriumand
near the left atrium (coronarysinus,left pulmonaryartery)
shouldresult in increasedmyocardialfieldstrengthand de-
creasedenergyloss.Thismayalsoexplaininpartwhyprevious
attemptsofhighandlowenergyshocksdeliveredbetweenone
electrodein the heart and one skinelectrode(15)or between
electrodesnot incorporatingthe left sideof the heart (16,18)
had lessfavorableresultsthan the methodof internalcardio-
versiondescribedhere.
In contrast to the energiesrequired for conversionof
inducedatrialfibrillationin animalsandhumans,whichrange
from 0.5 to 2.2 J on average(18-21,23,24),we used higher
energylevels(mean6.5 t 3.0J) in our patientswithchronic
atrial fibrillationafter failureof externalcardioversion.This
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may be explainedin part by the longer duration of atrial
fibrillationin our patientsand by the use of the pulmonary
arteryelectrodelocation,allofwhichcouldhaveresultedin a
higher actual energyrequirement(25-27).In our previous
reportofinternalcardioversionin a differentgroupofpatients,
weusedlowerenergylevels(mean3.7f 1.7J) (l). In thatpilot




energy levels for successfulinternal cardioversionin the
presentstudy.Characteristicssuchasa dilatedatriumandhigh
BMI(>25 kg/m2),likethoseencounteredin our patients,are
the mainreasonsfor failureof externalhighenergycardiover-
sion(12–15).Theseare thepatientswhomayespeciallybenefit
from internal cardioversion.Our data show that internal
cardioversionis worthwhileand highlyeffectiveeven after
failedexternalcardioversionattempts.Thesepatientshavean
88% successrate for regainingsinus rhythmby this new
methodafterestablishedtreatmentshavefailed.
In additionto the highsuccessrate the majoradvantageof
internal cardioversioncomparedwith externalhigh energy
shockapplicationis that the energyfor internalcardioversion
is muchlowerthan that normallyappliedwith conventional
externaldirectcurrentcardioversion.Therefore,atrialcardio-
versioncanbe performedwithoutgeneralanesthesia,and the
supervisionof an anesthesiologistis not necessary.Nonethe-
less,the meanatrialdefibrillationthresholdof6.5~ 3 J isstill
far abovethe pain thresholdfor mostpatients,but the proce-
dure was well toleratedwith a low dose of diazepamand
midazolam.
Follow-up, After cardioversion,all our patients were
treated with oral sotalol on the basis of positivereports
describinga highmaintenancerateofsinusrhythmafterdirect
current cardioversionof atrial fibrillationwith this drug
(10,11,28).Ourfollow-updataconfirmthesefindingsandshow
that the relapserate of atrialfibrillationiscomparableto that
after externalhighenergycardioversion(6).
Limitations of internal cardioversion.With any type of
energyapplicationto the heart at or exceedingthe pacing
threshold,thereissomeriskof inducingarrhythmia,evenwith
synchronizedshocks(29,30).This new method of internal
cardioversionis highlyeffectivebut nonethelessrequiresthe
insertionof catheters into the vascularsystemin patients
duringanticoagulation.It isan invasivetechnique,andallrisks
and limitationshaveto be considered.
Positioningof defibrillationelectrodesin the rightatrium,
pulmonaryartery or coronarysinus raises the questionof
whetherdamagecanresultfromthe energydeliveredthrough
the defibrillationelectrodes.Long-termimplantationof defi-
brillationelectrodesin the coronarysinusand other locations
in the heart has been usedwithoutadverseeffectsfor shock
applicationof energiesup to 30J for treatmentofventricular
fibrillationin patients(31,32).Therefore,it is unlikelythat
atrialdefibrillationfromthesesiteswouldresultin myocardial








cardioversionof atrial fibrillation.In the present study,we
presenteddata for patientswithfailedexternalcardioversion
only.Moreof thesepatientshad leadsin the left pulmonary
arterythan in the coronarysinus.Preliminarydata showthat
patientsassignedto a defibrillationlead in the coronarysinus
havelowerthresholdsthan thosewithleadslocatedin the left
pulmonaryartery(33).Theatrialdefibrillationthresholdof4.7
J witha coronarysinuslead in our studycorrelateswellwith
recentlypublishedresultsof a muhicentertrial (34)that used
a mean conversionvoltageof 313V (3.5J) of chronicatrial
fibrillationusingrightatrial and corona~ sinusdefibrillation
electrodes.
Clinical implications. In nearly90%of patientsin whom
external cardioversionfails, internal cardioversionwill be
successful,and >50% of these patientswillmaintainsinus
rhythmover the long term. Therefore,we recommendlow
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